Jefferies Group LLC set a $95.00 price objective on AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) in a research note released on Tuesday morning. The firm currently has a hold rating on the stock.

Several other analysts also recently commented on ABC. Vetr downgraded shares of AmerisourceBergen Corporation (Holding Co) from a strong-buy rating to a buy rating and set a $97.44 price objective on the stock. in a report on Tuesday, May 9th. Mizuho upped their price objective on shares of AmerisourceBergen Corporation (Holding Co) from $83.00 to $93.00 and gave the company a neutral rating in a report on Tuesday, May 30th. BidaskClub raised shares of AmerisourceBergen Corporation (Holding Co) from a hold rating to a buy rating in a report on Saturday, June 17th. Bank of America Corporation downgraded shares of AmerisourceBergen Corporation (Holding Co) from a buy rating to a neutral rating and dropped their price objective for the company from $95.76 to $94.00 in a report on Friday, June 30th. Finally, Zacks Investment Research downgraded shares of AmerisourceBergen Corporation (Holding Co) from a hold rating to a sell rating in a report on Monday, July 10th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of Hold and an average target price of $93.14.

AmerisourceBergen Corporation (ABC) opened at 80.24 on Tuesday. AmerisourceBergen Corporation has a 52-week low of $68.38 and a 52-week high of $97.85. The firm has a 50-day moving average of $84.65 and a 200 day moving average of $88.25. The company has a market capitalization of $17.58 billion, a P/E ratio of 20.91 and a beta of 0.91.

AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) last released its quarterly earnings data on Thursday, August 3rd. The company reported $1.43 EPS for the quarter, beating the consensus estimate of $1.37 by $0.06. The business had revenue of $38.71 billion for the quarter, compared to the consensus estimate of $39.13 billion. AmerisourceBergen Corporation (Holding Co) had a net margin of 0.56% and a return on equity of 56.07%. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same period in the prior year, the firm earned $1.37 EPS. Equities analysts predict that AmerisourceBergen Corporation will post $5.88 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://www.watchlistnews.com/jefferies-group-llc-analysts-give-amerisourcebergen-corporation-holding-co-abc-a-95-00-price-target/1537183.html.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 5th. Investors of record on Monday, August 21st will be issued a dividend of $0.365 per share. This represents a $1.46 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date is Thursday, August 17th. AmerisourceBergen Corporation (Holding Co)’s dividend payout ratio (DPR) is presently 38.02%.

In other AmerisourceBergen Corporation (Holding Co) news, insider Gina Clark sold 1,273 shares of the company’s stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $80.94, for a total transaction of $103,036.62. Following the completion of the transaction, the insider now directly owns 10,830 shares in the company, valued at $876,580.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Peyton R. Howell sold 20,000 shares of the company’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $80.00, for a total transaction of $1,600,000.00. Following the transaction, the insider now owns 57,135 shares of the company’s stock, valued at $4,570,800. The disclosure for this sale can be found here. Insiders have sold 36,273 shares of company stock worth $3,124,437 over the last three months. 27.40% of the stock is currently owned by insiders.

A number of institutional investors have recently bought and sold shares of the company. Parallel Advisors LLC boosted its position in AmerisourceBergen Corporation (Holding Co) by 3.2% in the second quarter. Parallel Advisors LLC now owns 1,109 shares of the company’s stock worth $104,000 after buying an additional 34 shares in the last quarter. Point72 Asia Hong Kong Ltd bought a new position in AmerisourceBergen Corporation (Holding Co) during the first quarter worth $105,000. American Beacon Advisors Inc. bought a new position in AmerisourceBergen Corporation (Holding Co) during the first quarter worth $108,000. SRS Capital Advisors Inc. boosted its position in AmerisourceBergen Corporation (Holding Co) by 0.3% in the first quarter. SRS Capital Advisors Inc. now owns 1,235 shares of the company’s stock worth $109,000 after buying an additional 4 shares in the last quarter. Finally, Sun Life Financial INC boosted its position in AmerisourceBergen Corporation (Holding Co) by 15,000.0% in the second quarter. Sun Life Financial INC now owns 1,208 shares of the company’s stock worth $114,000 after buying an additional 1,200 shares in the last quarter. Institutional investors own 67.66% of the company’s stock.

About AmerisourceBergen Corporation (Holding Co)

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Analyst Recommendations for AmerisourceBergen Corporation (Holding Co) (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related companies with Analyst Ratings Network's FREE daily email newsletter.